FDA
-
-
-
-
-
-
-
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
-
-
-
-
-
-
-
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
-
-
-
-
-
-
-
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m.
-
-
-
-
-
-
-
NeOnc Technologies reports ultrasound boosts NEO100 brain tumor treatment
-
-
-
-
-
-
-
NeOnc unit signs services pact with M42's IROS, expands board
-
-
-
-
-
-
-
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
-
-
-
-
-
-
-
NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors
-
323,901 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

